Saudi Arabia Steps up ‘Climate Battle’ Efforts

Part of the audience in the Saudi pavilion at the COP27 conference (Asharq Al-Awsat)
Part of the audience in the Saudi pavilion at the COP27 conference (Asharq Al-Awsat)
TT

Saudi Arabia Steps up ‘Climate Battle’ Efforts

Part of the audience in the Saudi pavilion at the COP27 conference (Asharq Al-Awsat)
Part of the audience in the Saudi pavilion at the COP27 conference (Asharq Al-Awsat)

The Saudi pavilion at COP27 was one of the most crowded places during the days of the conference in Sharm el-Sheikh.

Visitors did not only attend seminars and discussion sessions, they also met researchers who have introduced programs directed to combating climate change to light.

While Energy Minister Prince Abdulaziz bin Salman was active in leading the Saudi delegation during the days of his presence, which witnessed the launch of many Saudi-sponsored initiatives to confront climate change, researchers enriched the sessions with a lot of technical information on the nature and details of the initiatives.

During the summit, Prince Abdulaziz referred to many initiatives and concepts.

Those initiatives included the establishment of a regional center for the development of reducing emissions, and the launching of the Circular Carbon Economy Knowledge Hub at the beginning of 2023.

He also stressed the need to consolidate the circular carbon economy.

For his part, the Governor of the Public Investment Fund (PIF) and Chairman of Saudi Aramco, Yasir Al Rumayyan, said that Saudi Arabia’s Middle East Green Initiative (MGI) is a turning point in environmental efforts aiming to transition national ambitions into practical steps that affect the entire world.

Al Rumayyan underlined the great efforts being made by the Kingdom to build a green future, as part of its ambitions for carbon neutrality by 2060.

The Voluntary Carbon Market (VCM) Initiative was the first of its kind in the MENA region, Al Rumayyan said during the Saudi Green Initiative Forum.

The world’s largest-ever carbon credit auction took place last month, when 1.4 million tons of carbon credits were sold to 15 Saudi and regional entities. The PIF was also the first sovereign wealth fund to issue a 100-year tranche green bond, Al Rumayyan added.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.